Yang Rui, Cui Zhao, Hellmark Thomas, Segelmark Marten, Zhao Ming-hui, Wang Hai-yan
Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, PR China.
Clin Immunol. 2007 Aug;124(2):207-12. doi: 10.1016/j.clim.2007.05.001. Epub 2007 Jun 6.
Anti-GBM disease is a rare autoimmune condition characterized by autoantibodies targeting the alpha3 chain non-collagen 1 domain of type IV collagen (alpha3(IV)NC1). Recently, we isolated IgG reacting with alpha3(IV)NC1 from normal healthy human sera. The current study examined the antigen and epitope specificity of these natural autoantibodies (NAA) using recombinant human alpha1, 3, 5(IV)NC1 and three constructs expressing, previously defined epitope regions designated E(A), E(B) and S2, in the alpha1(IV)NC1 background. The NAA preparations reacted with recombinant human alpha3(IV)NC1 to the same extent as with purified bovine alpha(IV)NC1, but not with recombinant human alpha1 and alpha5(IV)NC1. NAA preparations recognized the three chimeric proteins (E(A), E(B) and S2) yielding similar absorbance values. We conclude that anti-GBM NAA recognize the same major epitopes as anti-GBM antibodies from patients with Goodpasture's disease.
抗肾小球基底膜(GBM)病是一种罕见的自身免疫性疾病,其特征是自身抗体靶向IV型胶原的α3链非胶原1结构域(α3(IV)NC1)。最近,我们从正常健康人血清中分离出了与α3(IV)NC1反应的IgG。本研究使用重组人α1、3、5(IV)NC1以及在α1(IV)NC1背景下表达先前定义的表位区域E(A)、E(B)和S2的三种构建体,检测了这些天然自身抗体(NAA)的抗原和表位特异性。NAA制剂与重组人α3(IV)NC1的反应程度与纯化的牛α(IV)NC1相同,但与重组人α1和α5(IV)NC1不发生反应。NAA制剂识别三种嵌合蛋白(E(A)、E(B)和S2),产生相似的吸光度值。我们得出结论,抗GBM NAA识别的主要表位与Goodpasture病患者的抗GBM抗体相同。